Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
53
COCSF Quote, Financials, Valuation and Earnings
Last price:
$8.0600
Seasonality move
:
-0.84%
Day range:
$7.7500 - $8.0620
52-week range:
$7.1500 - $10.8000
Dividend yield:
0%
P/E ratio:
13.70x
P/S ratio:
1.12x
P/B ratio:
2.37x
Volume:
6.1K
Avg. volume:
2.2K
1-year change:
-16.13%
Market cap:
$16.9B
Revenue:
$13.8B
EPS (TTM):
$0.59
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.1B | $8.6B | $9.6B | $11.3B | $13.8B | |
| Revenue Growth (YoY) | 6.38% | -14.74% | 11.58% | 17.3% | 22.74% | |
| Cost of Revenues | $5.6B | $4.7B | $5.2B | $6.3B | $7.6B | |
| Gross Profit | $4.5B | $3.9B | $4.4B | $5B | $6.3B | |
| Gross Profit Margin | 45% | 45.1% | 45.48% | 44.24% | 45.23% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.1B | $2.6B | $3B | $3.4B | $4.3B | |
| Other Inc / (Exp) | -$183.2M | -$161.9M | -$23.1M | -$122.6M | -$210.4M | |
| Operating Expenses | $3.2B | $2.7B | $3B | $3.5B | $4.3B | |
| Operating Income | $1.3B | $1.2B | $1.4B | $1.5B | $1.9B | |
| Net Interest Expenses | $193.6M | $266.1M | $205.3M | $118.4M | $103.2M | |
| EBT. Incl. Unusual Items | $956.1M | $754M | $1.1B | $1.3B | $1.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $293.3M | $254.6M | $326M | $325.4M | $495.6M | |
| Net Income to Company | $949.3M | $740.8M | $1.1B | $1.3B | $1.6B | |
| Minority Interest in Earnings | -$27.5M | -$2.9M | -$30.7M | -$29.4M | -$38.9M | |
| Net Income to Common Excl Extra Items | $628.5M | $483.4M | $774.8M | $946.1M | $1.1B | |
| Basic EPS (Cont. Ops) | $0.30 | $0.23 | $0.05 | $0.06 | $0.07 | |
| Diluted EPS (Cont. Ops) | $0.30 | $0.23 | $0.05 | $0.06 | $0.07 | |
| Weighted Average Basic Share | $2.1B | $2.1B | $16.8B | $16.8B | $16.8B | |
| Weighted Average Diluted Share | $2.1B | $2.1B | $16.8B | $16.8B | $16.8B | |
| EBITDA | $1.7B | $1.5B | $1.8B | $2B | $2.5B | |
| EBIT | $1.2B | $1.1B | $1.4B | $1.5B | $1.9B | |
| Revenue (Reported) | $10.1B | $8.6B | $9.6B | $11.3B | $13.8B | |
| Operating Income (Reported) | $1.3B | $1.2B | $1.4B | $1.5B | $1.9B | |
| Operating Income (Adjusted) | $1.2B | $1.1B | $1.4B | $1.5B | $1.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.4B | $2.8B | $3.7B | $3.7B | |
| Revenue Growth (YoY) | -15.37% | 13.87% | 16.89% | 30.53% | -0.15% | |
| Cost of Revenues | $1.2B | $1.3B | $1.6B | $2B | $2B | |
| Gross Profit | $968.8M | $1.1B | $1.3B | $1.7B | $1.7B | |
| Gross Profit Margin | 45.72% | 45.16% | 44.47% | 45.9% | 46.11% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$83.6M | $7.8M | $3.4M | $23.1M | $16.8M | |
| Operating Expenses | $644.7M | $768.8M | $894.1M | $1.2B | $1.2B | |
| Operating Income | $324.1M | $320.8M | $360.2M | $490.7M | $506.6M | |
| Net Interest Expenses | $63.6M | $70.5M | $34.1M | $57.7M | $55.9M | |
| EBT. Incl. Unusual Items | $176.8M | $258.2M | $329.5M | $456M | $467.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $59.9M | $84.7M | $107M | $133.1M | $144.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$5.3M | -$2.7M | -$6.5M | -$7.8M | -$14M | |
| Net Income to Common Excl Extra Items | $111.7M | $170.7M | $216.1M | $315.1M | $309.4M | |
| Basic EPS (Cont. Ops) | $0.05 | $0.08 | $0.10 | $0.15 | $0.15 | |
| Diluted EPS (Cont. Ops) | $0.05 | $0.08 | $0.10 | $0.15 | $0.15 | |
| Weighted Average Basic Share | $2.1B | $2.1B | $2.1B | $2.1B | $2.1B | |
| Weighted Average Diluted Share | $2.1B | $2.1B | $2.1B | $2.1B | $2.1B | |
| EBITDA | $253.9M | $338.7M | $395.7M | $556M | $568.4M | |
| EBIT | $253.9M | $338.7M | $395.7M | $556M | $568.4M | |
| Revenue (Reported) | $2.1B | $2.4B | $2.8B | $3.7B | $3.7B | |
| Operating Income (Reported) | $324.1M | $320.8M | $360.2M | $490.7M | $506.6M | |
| Operating Income (Adjusted) | $253.9M | $338.7M | $395.7M | $556M | $568.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9B | $9.4B | $10.8B | $13.3B | $15.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.9B | $5.1B | $6B | $7.3B | $8.2B | |
| Gross Profit | $4B | $4.3B | $4.8B | $6B | $6.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$270M | -$40.6M | -$58.2M | -$157.9M | -$119.7M | |
| Operating Expenses | $2.8B | $2.9B | $3.3B | $4.1B | $4.8B | |
| Operating Income | $1.2B | $1.3B | $1.5B | $1.8B | $2.1B | |
| Net Interest Expenses | $222.9M | $204.9M | $159.2M | $121.3M | $136.7M | |
| EBT. Incl. Unusual Items | $691.4M | $1.1B | $1.2B | $1.6B | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $246.4M | $377.9M | $341.4M | $375M | $604.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$2.2M | -$27.7M | -$29.4M | -$36M | -$49.8M | |
| Net Income to Common Excl Extra Items | $435.9M | $647M | $868.3M | $1.2B | $1.2B | |
| Basic EPS (Cont. Ops) | $0.21 | $0.31 | $0.41 | $0.56 | $0.59 | |
| Diluted EPS (Cont. Ops) | $0.21 | $0.31 | $0.41 | $0.56 | $0.59 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $1.1B | $1.3B | $1.5B | $1.8B | $2.1B | |
| EBIT | $959.9M | $1.3B | $1.5B | $1.8B | $2.1B | |
| Revenue (Reported) | $9B | $9.4B | $10.8B | $13.3B | $15.1B | |
| Operating Income (Reported) | $1.2B | $1.3B | $1.5B | $1.8B | $2.1B | |
| Operating Income (Adjusted) | $959.9M | $1.3B | $1.5B | $1.8B | $2.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.3B | $7B | $8.2B | $10.2B | $11.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.4B | $3.8B | $4.6B | $5.6B | $6.2B | |
| Gross Profit | $2.8B | $3.2B | $3.6B | $4.6B | $5.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$107.8M | $14.9M | -$19.9M | -$52.8M | $37.3M | |
| Operating Expenses | $2B | $2.2B | $2.5B | $3.2B | $3.7B | |
| Operating Income | $845.7M | $972.3M | $1.1B | $1.4B | $1.6B | |
| Net Interest Expenses | $254.1M | $198.2M | $151.7M | $157.2M | $192.3M | |
| EBT. Incl. Unusual Items | $483.7M | $789.1M | $898.5M | $1.2B | $1.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $158.2M | $279.7M | $294M | $345.8M | $453.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $6.2M | -$17.9M | -$16.5M | -$23.2M | -$34M | |
| Net Income to Common Excl Extra Items | $331.6M | $491.6M | $587.9M | $802.9M | $929.6M | |
| Basic EPS (Cont. Ops) | $0.16 | $0.23 | $0.28 | $0.38 | $0.44 | |
| Diluted EPS (Cont. Ops) | $0.16 | $0.23 | $0.28 | $0.38 | $0.44 | |
| Weighted Average Basic Share | $6.3B | $6.3B | $6.3B | $6.3B | $6.3B | |
| Weighted Average Diluted Share | $6.3B | $6.3B | $6.3B | $6.3B | $6.3B | |
| EBITDA | $785.9M | $1B | $1.1B | $1.5B | $1.7B | |
| EBIT | $785.9M | $1B | $1.1B | $1.5B | $1.7B | |
| Revenue (Reported) | $6.3B | $7B | $8.2B | $10.2B | $11.5B | |
| Operating Income (Reported) | $845.7M | $972.3M | $1.1B | $1.4B | $1.6B | |
| Operating Income (Adjusted) | $785.9M | $1B | $1.1B | $1.5B | $1.7B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $2.2B | $2.3B | $2.1B | $1.8B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $595.4M | $487.8M | $530.8M | $689M | $884.6M | |
| Inventory | $556.4M | $488.9M | $584.4M | $609.8M | $699.6M | |
| Prepaid Expenses | $71.5M | $81.5M | $88.2M | $86.9M | $53.1M | |
| Other Current Assets | $15.5M | $6.1M | $5.5M | $10.8M | $9.1M | |
| Total Current Assets | $3B | $3.6B | $3.9B | $4.1B | $4B | |
| Property Plant And Equipment | $3.3B | $3.1B | $3.1B | $3.8B | $4.8B | |
| Long-Term Investments | $525.2M | $391.9M | $373.6M | $433.5M | $544.5M | |
| Goodwill | $1.4B | $1.2B | $1.1B | $1.2B | $1.3B | |
| Other Intangibles | $4.6B | $4B | $3.9B | $4.1B | $4.6B | |
| Other Long-Term Assets | $156.6M | $85.6M | $78.3M | $82.3M | $68.8M | |
| Total Assets | $13.6B | $13.2B | $13.3B | $14.3B | $16.1B | |
| Accounts Payable | $1B | $864.3M | $1.1B | $1.4B | $1.6B | |
| Accrued Expenses | $568.7M | $539.1M | $620.4M | $332.8M | $415.3M | |
| Current Portion Of Long-Term Debt | $559.8M | $169.5M | $88.3M | $437.2M | $3.1M | |
| Current Portion Of Capital Lease Obligations | $25.5M | $28.1M | $30M | $24.2M | $44.3M | |
| Other Current Liabilities | $42.3M | $46.7M | $4.1M | $40.6M | $83.3M | |
| Total Current Liabilities | $2.7B | $2.2B | $2.3B | $3B | $3.2B | |
| Long-Term Debt | $3.1B | $4.1B | $4.1B | $3.6B | $3.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.8B | $7.1B | $7B | $7.5B | $8.2B | |
| Common Stock | $108.8M | $103.5M | $100.7M | $105.7M | $121.3M | |
| Other Common Equity Adj | -- | -- | -$243M | -$446.9M | -$843M | |
| Common Equity | $6.5B | $5.9B | $5.9B | $6.4B | $7.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $356.5M | $280.6M | $294.2M | $332.9M | $393.4M | |
| Total Equity | $6.8B | $6.2B | $6.2B | $6.8B | $7.9B | |
| Total Liabilities and Equity | $13.6B | $13.2B | $13.3B | $14.3B | $16.1B | |
| Cash and Short Terms | $1.1B | $2.2B | $2.3B | $2.1B | $1.8B | |
| Total Debt | $3.7B | $4.4B | $4.2B | $4B | $3.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | -- | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $399.4M | $435.1M | $707.3M | $814.6M | $844.3M | |
| Inventory | $436.4M | $664.4M | $652.9M | $660.7M | $710.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $476.2M | $322.1M | $476.8M | $474.7M | $441.2M | |
| Total Current Assets | $3.9B | $3.9B | $3.8B | $4.1B | $4.1B | |
| Property Plant And Equipment | $2.7B | $2.9B | $3.4B | $4.3B | $4.8B | |
| Long-Term Investments | $350.2M | $359.3M | $414.5M | $493.8M | $514M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $948.5M | $948.7M | $770.9M | $903.5M | $960.4M | |
| Total Assets | $12.7B | $13.1B | $13.5B | $15.7B | $15.7B | |
| Accounts Payable | $743.1M | $962.7M | $1.3B | $1.4B | $1.6B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $637.8M | $131.8M | $430.8M | $2.2M | $130.1M | |
| Current Portion Of Capital Lease Obligations | $24.8M | $27.2M | $25.2M | $34.7M | $41.6M | |
| Other Current Liabilities | $1.2B | $1.2B | $1.3B | $1.9B | $1.9B | |
| Total Current Liabilities | $2.6B | $2.4B | $3B | $3.4B | $3.6B | |
| Long-Term Debt | $4B | $4B | $3.3B | $3.8B | $3.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.1B | $7.1B | $7.2B | $8.2B | $8.1B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $249.8M | $288.4M | $313.2M | $376M | $383.8M | |
| Total Equity | $5.6B | $6B | $6.3B | $7.5B | $7.5B | |
| Total Liabilities and Equity | $12.7B | $13.1B | $13.5B | $15.7B | $15.7B | |
| Cash and Short Terms | $2.6B | $2.4B | $1.9B | $2.2B | $2.1B | |
| Total Debt | $4.6B | $4.2B | $3.7B | $3.8B | $3.7B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $949.3M | $740.8M | $1.1B | $1.3B | $1.6B | |
| Depreciation & Amoritzation | $519.5M | $470.4M | $485M | $518.2M | $594.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$96.5M | $142.6M | -$100.7M | -$170M | -$90.6M | |
| Change in Inventories | -$59.2M | $8.9M | -$111.6M | -$8.9M | -$44M | |
| Cash From Operations | $1.6B | $1.6B | $1.6B | $1.8B | $2.4B | |
| Capital Expenditures | $572.4M | $466.4M | $492.7M | $881.5M | $1.2B | |
| Cash Acquisitions | -- | -- | -- | -$144.8M | -$72.2M | |
| Cash From Investing | -$558M | -$492.8M | -$470.9M | -$974.1M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -$386.4M | -$482M | -$525.2M | -$569.8M | -$692.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $557.6M | $2.9B | $552M | $302.7M | $8.5M | |
| Long-Term Debt Repaid | -$1.1B | -$2.1B | -$730.9M | -$450.5M | -$513.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$17M | $17.1M | -$61.2M | -$76.9M | -$18.2M | |
| Cash From Financing | -$1.2B | $19.6M | -$999.4M | -$1B | -$1.5B | |
| Beginning Cash (CF) | $1.2B | $961M | $2.1B | $2.3B | $2.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$116.8M | $1.2B | $143.6M | -$246.2M | -$233.3M | |
| Ending Cash (CF) | $1.1B | $2B | $2.3B | $2B | $1.8B | |
| Levered Free Cash Flow | $1.1B | $1.2B | $1.1B | $882.6M | $1.2B | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2008-06-30 | 2009-06-30 | 2010-06-30 | 2011-06-30 | 2012-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $1.2B | $1.3B | $1.1B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-23 | 2022-12-23 | 2023-12-23 | 2024-12-23 | 2025-12-23 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get COCSF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
COCSF
Sector
P/E ratio
13.70x
--
PEG ratio
2.29x
--
P/B ratio
2.37x
--
Price / LTM sales
1.12x
--
Growth Metrics
COCSF
Sector
Revenue growth
-0.15%
--
Earnings growth
-1.76%
--
Revenue (5-year growth)
7.82%
--
Earnings forecast
--
--
Profitability
COCSF
Sector
Profitability FY 2023
$6.3B
--
Return on invested capital
10.88%
--
Return on assets
7.72%
--
Return on equity
16.32%
--
Earnings Date
Last Earnings Date
Oct
25
Next Earnings Date
Feb
21
Estimated Next Earnings Date
Jan
24
Balance Sheet
COCSF
Sector
Total cash
$2.1B
--
Short term investments
--
--
Total assets
$16.1B
--
Long term debt
$3.7B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
